𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Frequency of Protease and Reverse Transcriptase Drug Resistance Mutations in Naïve HIV-Infected Patients

✍ Scribed by Olivia M. Valle-Bahena; Javier Ramos-Jiménez; Rocío Ortiz-López; Agnès Revol; Ángel Lugo-Trampe; Hugo A. Barrera-Saldaña; Augusto Rojas-Martínez

Book ID
113466986
Publisher
Elsevier Science
Year
2006
Tongue
English
Weight
164 KB
Volume
37
Category
Article
ISSN
0188-4409

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

HIV-1 reverse transcriptase drug-resista
HIV-1 reverse transcriptase drug-resistance mutations in chronically infected individuals receiving or naïve to HAART in Cameroon
✍ Sherri T. Burda; Ragupathy Viswanath; Jiangqin Zhao; Thompson Kinge; Christopher 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB

## Abstract The most common first‐line, highly active anti‐retroviral therapy (HAART) received by individuals infected with HIV‐1 in Cameroon is the combination therapy Triomune, comprised of two nucleoside reverse transcriptase inhibitors (NRTI) and one non‐NRTI (NNRTI). To examine the efficacy of

Relationship between mutations in HIV-1
Relationship between mutations in HIV-1 RNase H domain and nucleoside reverse transcriptase inhibitors resistance mutations in naïve and pre-treated HIV infected patients
✍ Bénédicte Roquebert; Marc Wirden; Anne Simon; Jérome Deval; Christine Katlama; V 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB

## Abstract Recent studies have highlighted the need of investigating the in vivo role of ribonuclease H (RNase H) in nucleoside reverse transcriptase inhibitors (NRTIs) resistance. The prevalence of RNase H mutations in naive and in NRTI pre‐treated patients in regimen failure were compared and so